Somalogic (SLGC) Reports Prelim FY21 Revenues of Over $79M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
SomaLogic Announces Preliminary Revenue for Full Year 2021 Above Guidance Range
January 11, 2022 7:00 AM ESTPresenting at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. Eastern Time
BOULDER, Colo., Jan. 11, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced preliminary, unaudited revenue expectations for the year ending December 31st, 2021.
Preliminary, unaudited revenue for the full year 2021 is expected to exceed $79 million, the upper end of SomaLogics previously raised 2021 revenue guidance range, representing over 41% year-over-year revenue growth.
We are very pleased to announce these strong preliminary results which exceed our guidance and underscore the transformative... More
